{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:24:40Z","timestamp":1786944280191,"version":"build-2736575974"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder strongly linked to obesity and substantially increases the risk of cardiovascular and metabolic diseases. Sodium\u2013glucose cotransporter 2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and aerobic exercise have shown potential in improving OSA through distinct metabolic and physiological mechanisms. However, direct comparative evidence of their efficacy remains limited. This network meta-analysis aimed to compare the effects of SGLT2 inhibitors, GLP-1 receptor agonists, and aerobic exercise on OSA severity in overweight or obese patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched four electronic databases, PubMed, EMBASE, the Cochrane Library, and Web of Science, for articles published before October 31, 2025, without language restrictions. The analysis primarily included randomized controlled trials (RCTs); a limited number of case\u2013control studies were also incorporated due to the scarcity of direct comparative evidence. Primary efficacy outcomes were mean changes in the apnea\u2013hypopnea index (AHI), body mass index (BMI), mean peripheral oxygen saturation (SpO\n                      <jats:sub>2<\/jats:sub>\n                      ), and Epworth Sleepiness Scale (ESS) score. The certainty (confidence) of the evidence for every network estimate was appraised with the Confidence in Network Meta-Analysis (CINeMA) framework, which operationalizes the GRADE approach for network meta-analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 15 studies (13 RCTs and 2 case\u2013control studies) involving 1,877 participants were included in the analysis. GLP-1 receptor agonists demonstrated the greatest reduction in AHI compared with placebo (mean difference [MD] = \u221215.28 events\/h; 95% CI, \u221222.22 to \u22128.35). They also showed significant benefit versus placebo in lowering BMI (MD = \u22121.78 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ; 95% CI, \u22122.15 to \u22121.41) and improving mean SpO\n                      <jats:sub>2<\/jats:sub>\n                      (MD\u00a0=\u00a00.40%; 95% CI, 0.25 to 0.55). Although GLP-1 receptor agonists yielded a statistically significant improvement in ESS score versus placebo (MD = \u22120.20; 95% CI, \u22120.26 to \u22120.14), this effect was an order of magnitude below the 2-point minimal clinically important difference (MCID) for the ESS and is therefore not clinically meaningful. Aerobic exercise ranked highest in surface under the cumulative ranking curve (SUCRA) analysis for this outcome. No network estimate was rated as high certainty. Confidence was moderate for the effect of GLP-1 receptor agonists on BMI, low for their effects on AHI, mean SpO\n                      <jats:sub>2<\/jats:sub>\n                      , and ESS score versus placebo, and very low for all remaining comparisons, mainly because of within-study bias, imprecision, and suspected reporting bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Compared with placebo, GLP-1 receptor agonists reduced AHI and BMI and improved mean SpO\n                      <jats:sub>2<\/jats:sub>\n                      , and ranked highest for these outcomes in the SUCRA analysis. Comparisons between the active interventions, however, were largely non-significant and rested on indirect evidence, and the certainty of the evidence was moderate at best, being low or very low for most comparisons. This treatment hierarchy should therefore be regarded as hypothesis-generating rather than as a basis for firm clinical recommendations. Within these limits, these findings suggest that GLP-1 receptor agonists may offer a promising therapeutic approach for managing OSA in overweight or obese patients with metabolic comorbidities, though this remains to be confirmed in larger, high-quality, head-to-head trials.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1869479","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:35:27Z","timestamp":1786941327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of SGLT2 inhibitors, GLP-1 receptor agonists, and aerobic exercise for moderate-to-severe obstructive sleep apnea in overweight or obese patients: a network meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Jia","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucai","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshe","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Henan University of Chinese Medicine","place":["Zhengzhou, Henan, China"]},{"name":"Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-023-01496-3","article-title":"Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome","volume":"8","author":"Lv","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1038\/s41467-025-60218-1","article-title":"Global warming may increase the burden of obstructive sleep apnea","volume":"16","author":"Lechat","year":"2025","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00243-7","article-title":"Projecting the 30-year burden of obstructive sleep apnoea in the USA: a prospective modelling study","volume":"13","author":"Boers","year":"2025","journal-title":"Lancet Respir Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.17465","article-title":"Adherence to CPAP treatment and the risk of recurrent cardiovascular events: a meta-analysis","volume":"330","author":"S\u00e1nchez-de-la-Torre","year":"2023","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11325-025-03418-9","article-title":"Patterns and stability of long-term adherence in continuous positive airway pressure therapy for obstructive sleep apnea: a cohort study","volume":"29","author":"Jeppesen","year":"2025","journal-title":"Sleep Breath"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ejihpe14090163","article-title":"Adherence to CPAP therapy in obstructive sleep apnea: a prospective study on quality of life and determinants of use","volume":"14","author":"Milinovic","year":"2024","journal-title":"Eur J Investig Health Psychol Educ"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.02.059","article-title":"Interactions of obstructive sleep apnea with the pathophysiology of cardiovascular disease, part 1: JACC state-of-the-art review","volume":"84","author":"Javaheri","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23079","article-title":"International consensus statement on obstructive sleep apnea","volume":"13","author":"Chang","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03312-6","article-title":"Obstructive sleep apnea: an evolving therapeutic landscape with an emerging role for incretin-based therapies","volume":"42","author":"Xu","year":"2025","journal-title":"Adv Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5114\/amsad\/161170","article-title":"GLP-1 receptor agonists, SGLT2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy","volume":"8","author":"Papaetis","year":"2023","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12090224","article-title":"Therapeutic potential of glucagon-like peptide-1 receptor agonists in obstructive sleep apnea syndrome management: a narrative review","volume":"12","author":"Dragonieri","year":"2024","journal-title":"Diseases"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12050937","article-title":"Effect of SGLT2 inhibitors on polygraphic parameters in elderly patients affected by heart failure, type 2 diabetes mellitus, and sleep apnea","volume":"12","author":"Armentaro","year":"2024","journal-title":"Biomedicines"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000001208","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea","volume":"31","author":"D'Annibale","year":"2025","journal-title":"Curr Opin Pulm Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/lary.70022","article-title":"GLP-1 receptor agonists for obstructive sleep apnea: an otolaryngologist's prescription","volume":"136","author":"Zgardau","year":"2026","journal-title":"Laryngoscope"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-025-09436-3","article-title":"Effectiveness of aerobic exercise training in patients with obstructive sleep apnea: a systematic review and meta-analysis","volume":"283","author":"Pawar","year":"2026","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1590\/S1806-37562016000000156","article-title":"The role of physical exercise in obstructive sleep apnea","volume":"42","author":"Andrade","year":"2016","journal-title":"J Bras Pneumol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae280","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis","volume":"48","author":"Li","year":"2025","journal-title":"Sleep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.70196","article-title":"Evaluating the efficacy of sodium glucose cotransporter-2 inhibitors in management of obstructive sleep apnea; a systematic review and meta-analysis","volume":"35","author":"Murtaza","year":"2026","journal-title":"J Sleep Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.11310","article-title":"Effects of aerobic exercise and resistance training on obstructive sleep apnea: a systematic review and meta-analysis","volume":"20","author":"Lin","year":"2024","journal-title":"J Clin Sleep Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"B23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5664\/jcsm.2172","article-title":"Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine","volume":"8","author":"Berry","year":"2012","journal-title":"J Clin Sleep Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1183\/13993003.01148-2015","article-title":"Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms","volume":"47","author":"Arnardottir","year":"2016","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116383","article-title":"Construct validity and factor structure of the Pittsburgh sleep quality index and Epworth sleepiness scale in a multi-national study of African, South East Asian and South American college students","volume":"9","author":"Gelaye","year":"2014","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/resp.12204","article-title":"Clinical use of pulse oximetry: official guidelines from the Thoracic Society of Australia and New Zealand","volume":"19","author":"Pretto","year":"2014","journal-title":"Respirology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/948717","article-title":"Examination of pulse oximetry tracings to detect obstructive sleep apnea in patients with advanced chronic obstructive pulmonary disease","volume":"21","author":"Scott","year":"2014","journal-title":"Can Respir J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab030","article-title":"Metrics of sleep apnea severity: beyond the apnea-hypopnea index","volume":"44","author":"Malhotra","year":"2021","journal-title":"Sleep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PloS Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"B32","article-title":"Interventions for the treatment of obstructive sleep apnea in adults: a health technology assessment","author":"Kim","year":"2017"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201704-0672LE","article-title":"The Epworth sleepiness scale: minimum clinically important difference in obstructive sleep apnea","volume":"197","author":"Patel","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-024-03643-3","article-title":"DAHOS study: efficacy of dapagliflozin in treating heart failure with reduced ejection fraction and obstructive sleep apnea syndrome - a 3-month, multicenter, randomized controlled clinical trial","volume":"80","author":"Xie","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41387-019-0098-5","article-title":"Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study","volume":"9","author":"Tang","year":"2019","journal-title":"Nutr Diabetes"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.106853","article-title":"Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: time course and association with body weight","volume":"136","author":"Malhotra","year":"2025","journal-title":"Sleep Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0\u2009mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-022-02768-y","article-title":"Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea","volume":"27","author":"Jiang","year":"2023","journal-title":"Sleep Breath"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1378\/chest.98.2.325","article-title":"Treatment of obstructive sleep apnea with glucagon like peptide-1 receptor agonist","volume":"191","author":"Amin","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-018-1736-1","article-title":"Effects of 12 weeks of regular aerobic exercises on autonomic nervous system in obstructive sleep apnea syndrome patients","volume":"22","author":"Yang","year":"2018","journal-title":"Sleep Breath"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17176334","article-title":"Effect of a graduated walking program on the severity of obstructive sleep apnea syndrome. A randomized clinical trial","volume":"17","author":"Jurado-Garc\u00eda","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B44","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.1038\/s41598-022-13115-2","article-title":"Effects of exercise training on brain metabolism and cognitive functioning in sleep apnea","volume":"12","author":"Ueno-Pardi","year":"2022","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2023.11.008","article-title":"Effect of high-intensity interval training on obstructive sleep apnea severity: a randomized controlled trial","volume":"112","author":"Lins-Filho","year":"2023","journal-title":"Sleep Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003654","article-title":"Effect of 12-week high-intensity interval training on hemodynamic variables at rest and during exercise in patients with obstructive sleep apnoea","volume":"42","author":"Lins-Filho","year":"2024","journal-title":"J\u00a0Hypertens"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01897-2015","article-title":"Effects of exercise training on sleep apnoea in patients with coronary artery disease: a randomised trial","volume":"48","author":"Mendelson","year":"2016","journal-title":"Eur Respir J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2018.0197","article-title":"The effect of T'ai Chi and Qigong training on patients with obstructive sleep apnea: a randomized controlled study","volume":"25","author":"Yilmaz Gokmen","year":"2019","journal-title":"J Altern Complement Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11325-025-03521-x","article-title":"Obesity, obstructive sleep apnea, and cardiometabolic risk: a comparative analysis of population-based cohorts in Switzerland, India, and Benin","volume":"29","author":"Goyal","year":"2025","journal-title":"Sleep Breath"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00846-6","article-title":"Obstructive sleep apnoea heterogeneity and cardiovascular disease","volume":"20","author":"Redline","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.11682","article-title":"Evaluating the potential of metabolic drugs in obstructive sleep apnea and obesity: a narrative review","volume":"21","author":"Sevencan","year":"2025","journal-title":"J Clin Sleep Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2024.10.026","article-title":"Efficacy comparison of aerobic exercise, combined exercise, oropharyngeal exercise and respiratory muscle training for obstructive sleep apnea: a systematic review and network meta-analysis","volume":"124","author":"Tang","year":"2024","journal-title":"Sleep Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea: a review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/frsle.2024.1524593","article-title":"Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies","volume":"3","author":"Wei","year":"2025","journal-title":"Front Sleep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2026.156494","article-title":"Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond","volume":"177","author":"Muzurovi\u0107","year":"2026","journal-title":"Metabolism"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101473","article-title":"New frontiers in pharmacologic obstructive sleep apnea treatment: a narrative review","volume":"57","author":"Sch\u00fctz","year":"2021","journal-title":"Sleep Med Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"160110","DOI":"10.1183\/16000617.0110-2016","article-title":"Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk","volume":"26","author":"Dobrosielski","year":"2017","journal-title":"Eur Respir Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013449.pub2","article-title":"Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea","volume":"11","author":"Rueda","year":"2020","journal-title":"Cochrane Database Systematic Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191710845","article-title":"Effects of exercise on patients with obstructive sleep apnea: a systematic review and meta-analysis","volume":"19","author":"Peng","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B61","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2025.01.021","article-title":"Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation","volume":"138","author":"Moiz","year":"2025","journal-title":"Am J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1789371","article-title":"Comparative effects of weight-loss diet, exercise training, respiratory muscle training, and oropharyngeal muscle training in obstructive sleep apnea: a systematic review and network meta-analysis","volume":"13","author":"Lin","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04071-1","article-title":"Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial","volume":"32","author":"Malhotra","year":"2026","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111984","article-title":"Bidirectional interplay of sleep apnea syndrome and cardio-vascular disorders in diabetes","volume":"220","author":"Valensi","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad572","article-title":"Approach the patient with obstructive sleep apnea and obesity","volume":"109","author":"Meyer","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2025.07.024","article-title":"Residual excessive daytime sleepiness in obstructive sleep apnoea and new pharmacological possibilities for treatment","volume":"61","author":"Oscullo","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-025-01175-7","article-title":"Comparative efficacy and safety of multiple wake-promoting agents for the treatment of residual sleepiness in obstructive sleep apnea despite continuous positive airway pressure: a systematic review and network meta-analysis of randomized controlled trials","volume":"39","author":"Tanayapong","year":"2025","journal-title":"CNS Drugs"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1387924","article-title":"Revealing inconsistencies between Epworth scores and apnea-hypopnea index when evaluating obstructive sleep apnea severity: a clinical retrospective chart review","volume":"15","author":"Amiri","year":"2024","journal-title":"Front Neurol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaf165","article-title":"Characteristics of maintenance of wakefulness test in drug-na\u00efve patients with narcolepsy type 1 and type 2, and relationship with other measures of sleepiness","volume":"49","author":"Biscarini","year":"2026","journal-title":"Sleep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1869479\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:35:48Z","timestamp":1786941348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1869479\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":70,"alternative-id":["10.3389\/fendo.2026.1869479"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1869479","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1869479"}}